Delivery Order SPE2DR25D1109-SPE2DR26FFG2M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xeomin 100 Unit Vials with a ceiling value of $35,535.50 under a firm fixed-price contract. This non-set-aside award is scheduled for completion by October 8, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a competitively awarded procurement action sourced through the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Xeomin 100 unit vials, with a ceiling value of $1,676.22 and a firm fixed price structure. The order is expected to be completed by November 21, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for 100-unit vials of Xeomin on October 23, 2025, with a ceiling value of $5,888.20 and completion date of November 14, 2025. This firm fixed-price, non-set-aside delivery order is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child award, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $20,114.64 for 100-unit vials of Xeomin on September 18, 2025, with completion scheduled for October 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded procurement supporting federal medical supply requirements. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Xeomin 200 unit vials valued at $23.5K with a completion date of September 16, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor serving federal...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 2, 2025, for the supply of Xeomin 100 Unit Vials, with a ceiling value of $23,467.08 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with a completion date of July 24, 2025, to be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $19,569.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 3, 2025, for the supply of Xeomin 100 Unit Vials, with completion required by January 27, 2025. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,793.70 firm fixed-price delivery order for 100-unit vials of Xeomin on July 11, 2025, with an ultimate completion date of August 1, 2025. The order will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger federal contract portfolio with the DLA. This...
- AmerisourceBergen Drug Corp was awarded a $5,587.40 delivery order by the Defense Logistics Agency (DLA) on October 23, 2025, for the supply of 100-unit vials of Xeomin. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,609.60 to AmerisourceBergen Drug Corp for the supply of Xeomin 50 Unit Vials. This firm fixed-price, non-set-aside contract was awarded on November 4, 2025, with an ultimate completion date of November 26, 2025. The place of performance is located in Conshohocken, Pennsylvania, the vendor's corporate headquarters. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFG2MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Xeomin 200 Unit Vials, with a ceiling value of $23,553.20 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement, particularly serving the Defense Health Agency and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. The Xeomin delivery order represents one of numerous competitively awarded transactions through the DLA Troop Support Medical contract, showcasing AmerisourceBergen's versatility in fulfilling specialized federal medical supply needs for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.6k | 11/7/25 |